CTI-BMI

3 papers2 findings

Humans3

Associations

1

Cardiovascular-liver-metabolic multimorbidity

upin humans1OR 3.46

1 study

CTI-BMI predicts cardiovascular-liver-metabolic multimorbidity in humans (AUC 0.638, 95% CI 0.611-0.664).
Humansapproximately four-yearn = 6,534
Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study
Cardiovascular diabetology26 Aug 2026
CTI-BMI raises the risk of cardiovascular-liver-metabolic multimorbidity in humans (Q4 OR 3.46, P <0.001).
Humansfully adjusted modelapproximately four-yearn = 6,534
Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study
Cardiovascular diabetology26 Aug 2026

More on Cardiovascular-liver-metabolic multimorbidity

Latest

3 in 12 months

Diabetes Research and Clinical Practice30 Aug

Associations of C-reactive protein-triglyceride glucose-related indices with mortality across glycemic states: a nationwide prospective cohort study

Cohort study of 13,867 peopleBiomarkers

Cardiovascular Diabetology29 Aug

Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study

Cohort study of 6,534 peopleGlucose

Therapeutic Advances in Endocrinology and Metabolism13 Aug

From traditional to novel: a national cohort study on the predictive value of C-reactive protein-triglyceride-glucose-obesity composite parameters for cardiovascular disease

Cohort study of 7,847 peopleC-reactive protein